Maximizing HPV Vaccination: Real-time Reminders, Guidance, and Recommendations - Part 4: Feasibility Trial

Human papillomavirus (HPV) vaccines have potential to prevent an average of 26,900 cancer cases each year in the United States, but vaccine coverage rates remain low. The study team has developed an electronic application (app), Protect Me 4, to help parents and providers assess and have more productive conversations about needed vaccines. The specific aims of this study are to: (1) evaluate the feasibility of implementing Protect Me 4, and (2) estimate preliminary efficacy of Protect Me 4 to increase HPV vaccine initiation (receipt of first dose).

Inclusion Criteria: * Must be parent of an adolescent aged 11-12 years old. * Providers working with age appropriate for study adolescents at the intervention clinics * Adolescents/Parents/Providers willing to consent to participation * Adolescents/Parents that can read and speak English Exclusion Criteria: * Adolescents out of the age range for participation * Adolescents/Parents/Providers unwilling to consent to participation * Adolescents/Parents that can NOT read and speak English